DFMDA

Overview

DFMDA (Difluoromethylenedioxyamphetamine) is a synthetic compound that belongs to the class of substituted amphetamines. It is structurally related to MDMA (3,4-methylenedioxy-N-methylamphetamine), a well-known psychoactive drug. DFMDA is characterized by the presence of a difluoromethylenedioxy group attached to the amphetamine backbone.

Chemical Structure

Chemical structure of DFMDA

The chemical structure of DFMDA includes a phenethylamine core with a difluoromethylenedioxy group attached to the benzene ring. This modification is responsible for its unique pharmacological properties compared to other amphetamines.

Pharmacology

DFMDA acts primarily as a serotonin releasing agent, similar to other compounds in the substituted amphetamine class. It affects the central nervous system by increasing the release of serotonin, leading to altered mood and perception. The presence of the difluoromethylenedioxy group may influence its potency and duration of action.

Potential Uses

While DFMDA is primarily of interest in research settings, its potential applications could include studies on neurotransmitter release and the development of new therapeutic agents for mood disorders. However, its safety and efficacy in humans have not been established.

Legal Status

As a research chemical, DFMDA is not approved for medical use and is subject to legal restrictions in many jurisdictions. It is important for researchers to comply with local regulations when handling this compound.

Related Compounds

DFMDA is part of a broader class of substituted amphetamines, which includes:

• MDMA
• MDA (3,4-methylenedioxyamphetamine)
• MDEA (3,4-methylenedioxy-N-ethylamphetamine)

Related Pages

• Amphetamine
• Serotonin
• Psychoactive drug